Literature DB >> 23356595

Theory of mind deficits in Parkinson's disease: a product of executive dysfunction?

Clare M Eddy1, Sarah R Beck, Ian J Mitchell, Peter Praamstra, Hardev S Pall.   

Abstract

OBJECTIVE: Patients with Parkinson's disease (PD) can perform poorly on tasks involving theory of mind (ToM): the ability to reason about mental states. We investigated whether patients' ToM deficits were independent of executive dysfunction.
METHOD: Experiment 1 aimed to establish that ToM deficits were present, and 2 following experiments manipulated the working memory (WM) demands of the ToM task.
RESULTS: In Experiment 1, 15 patients with PD performed significantly more poorly than controls on a false belief vignette task but not on a faux pas task. Errors were related to poor verbal fluency. In Experiment 2, 24 patients with PD made fewer errors on shorter false belief vignettes than the original FBT, and errors on the latter were related to WM impairment. In Experiment 3, the FBT was presented as a comic strip visible throughout questioning, reducing WM demands. Patients (n = 24) made memory errors but no false belief errors on the comic strip. They exhibited no verbal fluency or WM impairments, but did exhibit deficits on a black-and-white Stroop task. False belief errors were not correlated with executive performance.
CONCLUSIONS: PD patients made very few ToM errors that were independent of errors on memory questions, so in this sample, ToM deficits per se appear unlikely. However, patients still made errors on ToM tasks when associated incidental WM demands were considerably reduced, highlighting the need for future investigations of ToM in PD to account for the role of more general cognitive restrictions exhibited by even some medicated, early stage patients.

Entities:  

Mesh:

Year:  2013        PMID: 23356595     DOI: 10.1037/a0031302

Source DB:  PubMed          Journal:  Neuropsychology        ISSN: 0894-4105            Impact factor:   3.295


  8 in total

1.  Social cognition and idiopathic isolated cervical dystonia.

Authors:  Kristína Czekóová; Petra Zemánková; Daniel J Shaw; Martin Bareš
Journal:  J Neural Transm (Vienna)       Date:  2017-04-25       Impact factor: 3.575

2.  The effect of cognitive status and visuospatial performance on affective theory of mind in Parkinson's disease.

Authors:  Audrey McKinlay; Michelle Albicini; Phillip S Kavanagh
Journal:  Neuropsychiatr Dis Treat       Date:  2013-08-06       Impact factor: 2.570

3.  Social Cognition Impairments in Mice Overexpressing Alpha-Synuclein Under the Thy1 Promoter, a Model of Pre-manifest Parkinson's Disease.

Authors:  Iddo Magen; Eileen Ruth Torres; Diana Dinh; Andrew Chung; Eliezer Masliah; Marie-Françoise Chesselet
Journal:  J Parkinsons Dis       Date:  2015       Impact factor: 5.568

4.  The Edinburgh Social Cognition Test (ESCoT): Examining the effects of age on a new measure of theory of mind and social norm understanding.

Authors:  R Asaad Baksh; Sharon Abrahams; Bonnie Auyeung; Sarah E MacPherson
Journal:  PLoS One       Date:  2018-04-17       Impact factor: 3.240

Review 5.  Disruption of Inferior Longitudinal Fasciculus Microstructure in Parkinson's Disease: A Systematic Review of Diffusion Tensor Imaging Studies.

Authors:  Maryam Haghshomar; Mahsa Dolatshahi; Farzaneh Ghazi Sherbaf; Hossein Sanjari Moghaddam; Mehdi Shirin Shandiz; Mohammad Hadi Aarabi
Journal:  Front Neurol       Date:  2018-07-26       Impact factor: 4.003

6.  Impairment in Theory of Mind in Parkinson's Disease Is Explained by Deficits in Inhibition.

Authors:  Jennifer A Foley; Claire Lancaster; Elena Poznyak; Olga Borejko; Elaine Niven; Thomas Foltynie; Sharon Abrahams; Lisa Cipolotti
Journal:  Parkinsons Dis       Date:  2019-05-28

Review 7.  Neurocognitive mechanisms of theory of mind impairment in neurodegeneration: a transdiagnostic approach.

Authors:  Cherie Strikwerda-Brown; Siddharth Ramanan; Muireann Irish
Journal:  Neuropsychiatr Dis Treat       Date:  2019-02-20       Impact factor: 2.570

8.  Affective theory of mind in Parkinson's disease: the effect of cognitive performance.

Authors:  Ana-Maria Romosan; Liana Dehelean; Radu-Stefan Romosan; Minodora Andor; Ana Cristina Bredicean; Mihaela Adriana Simu
Journal:  Neuropsychiatr Dis Treat       Date:  2019-08-30       Impact factor: 2.570

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.